Produced by FemHealth Insights and hosted by CEO, Dr. Brittany Barreto, the FemTech Focus podcast engages people supporting, investing, and innovating in the FemHealth market to talk about present innovations and the future of female health and wellness. Why were women excluded from clinical trials till 1993? How is the US maternity mortality rate rising so quickly? When will we have effective treatments for menopause? These provocative questions and more are posed to expert guests while highlighting innovative solutions improving women's health.
Site
RSS
Apple
Data updated on 04/07/2026
Recent rankings
Latest chart positions across Apple Podcasts and Spotify rankings.
Shared links between episodes and podcasts
Links found in episode descriptions and other podcasts that share them.
OMG it's OTC: Opill the First FDA Approved Over the Counter Birth Control - Episode 235
Episode 246
Wednesday, May 15, 2024 • Duration 43:37
In this episode, we talk to Irene Laurora, SVP of Scientific Affairs, and Flavia Mason, global VP of women’s health at Perrigo, a consumer health company. Their over the counter birth control, Opill, was the first to receive FDA approval in the US, a significant step towards decreasing barriers for women to access quality healthcare. Join us for a conversation where we discuss the societal role of hormonal birth control, Perrigo’s journey to securing FDA approval for Opill, and whether Opill is right for you.
Remember to like, rate, and subscribe. Enjoy the episode!
Guest bio
Irene Laurora is a pharmacist by training who has spent her career in the pharmaceutical industry working to build solutions that make people’s lives better and healthier. She currently serves as the SVP of Scientific Affairs at Perrigo, where she has played an instrumental role in the development of products like Opill.
Flavia Mason is the Global VP of Women’s Health at Perrigo. She came to this role after many years in corporate America, where she proved herself to be a strong leader and capable operator. She joined Perrigo to help improve women’s experiences when interacting with the healthcare system.
Organization bio
Perrigo is a consumer health company responsible for securing FDA approval for the first over the counter birth control in the US, the Opill. Perrigo is behind many of the personal health brands you may be familiar with and see at your local pharmacy. With the addition of the Opill, consumers are now able to walk into a pharmacy, big box retailer, or favorite e-commerce platform, and access hormonal birth control pills without doctor’s appointment or prescription. It is a massive step forward in reducing barriers to accessing healthcare for women.
FemTech Focus Podcast bio
The FemTech Focus Podcast is brought to you by FemHealth Insights, the leader in Women’s Health market research and consulting. In this show, Dr. Brittany Barreto hosts meaningfully provocative conversations that bring FemTech experts - including doctors, scientists, inventors, and founders - on air to talk about the innovative technology, services, and products (collectively known as FemTech) that are improving women's health and wellness. Though many leaders in FemTech are women, this podcast is not specifically about female founders, nor is it geared toward a specifically female audience. The podcast gives our host, Dr. Brittany Barreto, and guests an engaging, friendly environment to learn about the past, present, and future of women’s health and wellness.
FemHealth Insights bio
Led by a team of analysts and advisors who specialize in female health, FemHealth Insights is a female health-specific market research and analysis firm, offering businesses in diverse industries unparalleled access to the comprehensive data and insights needed to illuminate areas of untapped potential in the nuanced women’s health market.
Time Stamps
[02:10] Flavia and Irene’s backgrounds
[09:38] Description of Perrigo and explanation of connection to women’s health
[12:45] What is Opill?
[16:02] Other forms of over the counter contraception
[20:20] Stats around unintended pregnancy in the US
[23:48] Effectiveness of OTC birth control
[29:38] The FDA approval process for Opill
[32:12] How Perrigo is helping increase access to birth control
[35:10] Is Opill right for you?
[37:12] Is OTC birth control new to the world? Or just new to the US?
[38:50] Looking ahead: aspirations for Opill and Perrigo
Tackling Vulvodynia and Building Community with Gaia Salizzoni of Hale - Episode 234
Episode 245
Wednesday, May 1, 2024 • Duration 34:59
In this episode, we talk to Gaia Salizzoni, founder of Hale, a community for women suffering from genito-pelvic pain, including vulvodynia. Her community is an important part of the care journey for patients going through treatment or dealing with genito-pelvic pain. Additionally, as an entrepreneur building a women’s health company in the EU, Gaia has a unique view into the advantages and difficulties building in Europe. Join us for a conversation where we discuss the Hale community, genito-pelvic pain, and the current state of women’s health innovation in the EU.
Remember to like, rate and subscribe and enjoy the episode!
Guest bio
Gale Salizzoni is founder and CEO of Hale, a digital platform designed to help people living with genito-pelvic pain improve their quality of life. With a passion for women's health and a background in technology, Gaia founded Hale to provide support and resources for those navigating the challenges of pelvic and gynecologic pain. Through Hale, Gaia aims to empower individuals to better manage their condition and find relief from discomfort, fostering a community of understanding and support along the way.
Organization bio
Hale is a supportive community tailored for women experiencing genito-pelvic pain, offering a safe space for connection, understanding, and shared healing journeys. Through online forums, resources, and expert guidance, Hale provides women with the tools and solidarity to navigate their pain experiences with empowerment and resilience. With a focus on holistic well-being and destigmatization, Hale fosters a compassionate environment where women can find comfort, validation, and hope amidst their challenges.
FemTech Focus Podcast bio
The FemTech Focus Podcast is brought to you by FemHealth Insights, the leader in Women’s Health market research and consulting. In this show, Dr. Brittany Barreto hosts meaningfully provocative conversations that bring FemTech experts - including doctors, scientists, inventors, and founders - on air to talk about the innovative technology, services, and products (collectively known as FemTech) that are improving women's health and wellness. Though many leaders in FemTech are women, this podcast is not specifically about female founders, nor is it geared toward a specifically female audience. The podcast gives our host, Dr. Brittany Barreto, and guests an engaging, friendly environment to learn about the past, present, and future of women’s health and wellness.
Nurx by Thirty Madison Brings Women’s Healthcare to Your Mailbox – Episode 233
Episode 244
Wednesday, April 17, 2024 • Duration 43:20
In this episode, we talk with Michelle Carnahan, President of Thirty Madison. Thirty Madison is a direct-to-consumer healthcare company intended to provide specialized care to individuals with chronic conditions. They currently operate four unique brands: Keeps, Cove, Evens, and Picnic focused on treating hair loss, migraines, GI issues, and allergies respectively.
Michelle and Brittany discuss Thirty Madison’s leadership in delivering digital health for women through their portfolio of brands, including NURX. They also touch on some of the challenges women face in accessing quality healthcare and how Thirty Madison and NURX are helping solve these problems.
Remember to like, rate and subscribe and enjoy the episode!
Correction: Nurx was acquired by Thirty Madison in 2022 when the company was seven.
Guest bio
Michelle Carnahan has spent her entire career ensuring patients get the treatments they need to live a happy and healthy life. After graduating from college, Michelle joined Eli Lilly as a pharmaceutical sales rep. Fast forward 26 years and she will have led two of their largest product lines before launching their international business unit in 2017. She joined Thirty Madison as President in July of 2020 — just as the pandemic was reaching its head and digital technology adoption was fueling rapid changes in the way consumers access care. Within a year of joining, Michelle helped Thirty Madison to a $140M Series C raise with a valuation of over $1BN led by HealthQuest Capital.
Organization bio
Thirty Madison is a direct-to-consumer healthcare company intended to provide specialized care to individuals with chronic conditions. They currently operate four unique brands: , , , and focused on treating hair loss, migraines, GI issues, and allergies respectively.
Investing in FemTech in LATAM with Daniela Pacheco – Episode 232
Episode 243
Wednesday, April 10, 2024 • Duration 41:54
In this episode, we talk to Daniela Pacheco, Managing Partner and Portfolio Manager at New Ventures Capital, where she leverages her 12 years of experience working with high impact entrepreneurs to identify and scale promising founders and startups. Join us for a conversation where we discuss the current state of women’s health innovation in Latin America, cultural considerations unique to the region, and the areas that present the greatest opportunity for growth.
You can connect with Daniela on LinkedIn through Empodera Impact Capital.
Remember to like, rate and subscribe and enjoy the episode!
Guest bio
Daniela Pacheco is Managing Partner and Portfolio Manager at New Ventures Capital. She is actively deploying through her new fund Empodera Impact Capital, which is focused on women’s health. She started her career at Endeavor in recruitment and services, managing the pipeline and portfolios for education, agriculture and health. At Endeavor, she found her purpose to support companies’ scale.
Prior to her role at New Ventures, she worked within tech startups and at venture capital funds in portfolio management. These experiences have helped her develop her skills as an operator and investor. She holds a degree of Business Administration with concentration in Economics Babson College, and a Masters in Entrepreneurship and Innovation from USC.
Organization bio
Based in Bogota Colombia, New Ventures is an Impact Fund Manager that designs, operates, and oversees different impact-related assets. NVC supports both impact-driven entrepreneurs with disruptive business models and mission-oriented investors to connect in order to drive social and environmental wellbeing.
FemTech Focus Podcast bio
The FemTech Focus Podcast is brought to you by FemHealth Insights, the leader in Women’s Health market research and consulting. In this show, Dr. Brittany Barreto hosts meaningfully provocative conversations that bring FemTech experts - including doctors, scientists, inventors, and founders - on air to talk about the innovative technology, services, and products (collectively known as FemTech) that are improving women's health and wellness. Though many leaders in FemTech are women, this podcast is not specifically about female founders, nor is it geared toward a specifically female audience. The podcast gives our host, Dr. Brittany Barreto, and guests an engaging, friendly environment to learn about the past, present, and future of women’s health and wellness.
Optimizing Preconception Wellness with Poplin – Episode 231
Episode 242
Wednesday, March 27, 2024 • Duration 42:55
In this episode, we talk to Alexandria DeVito, founder of Poplin. Poplin is the first preconception wellness testing company, designed to help couples understand their health and how it may impact their fertility long before they are interested in actively trying to have a baby.
Join us for a conversation where we define “preconception wellness,” discuss how Alexandria leveraged her unique interests to create a company and change lives, and learn more about what it’s like to write a book.
Check out Alexandria’s book 9 Months is Not Enough, here, and use code “femtech” for 10% off your Poplin kit.
Remember to like, rate and subscribe and enjoy the episode!
Guest bio
Alexandria DeVito, founder of Poplin, a preconception wellness testing company, brings a wealth of experience to the table. With a background rooted in healthcare and a passion for empowering women, she's dedicated to revolutionizing the way we approach family planning. Her commitment to innovation and impact is evident not only in her work with Poplin but also in her book, "9 Months Is Not Enough," where she shares invaluable insights into navigating the journey to motherhood. With her blend of expertise, empathy, and entrepreneurial spirit, Alexandria is a driving force in shaping the future of women's health.
Organization bio
Poplin is the first preconception wellness company, helping couples understand and improve their health in order to increase their odds of conceiving, whenever that may be. With fertility health as a leading indicator of overall health, Poplin’s tests help users understand their overall health, not just in the context of getting pregnant.
Additionally, Alexandria’s book 9 Months is Not Enough provides readers with a comprehensive checklist on how to best prepare their bodies for pregnancy. A must-read for anyone interested in having a baby.
FemTech Focus Podcast bio
The FemTech Focus Podcast is brought to you by FemHealth Insights, the leader in Women’s Health market research and consulting. In this show, Dr. Brittany Barreto hosts meaningfully provocative conversations that bring FemTech experts - including doctors, scientists, inventors, and founders - on air to talk about the innovative technology, services, and products (collectively known as FemTech) that are improving women's health and wellness. Though many leaders in FemTech are women, this podcast is not specifically about female founders, nor is it geared toward a specifically female audience. The podcast gives our host, Dr. Brittany Barreto, and guests an engaging, friendly environment to learn about the past, present, and future of women’s health and wellness.
Tackling IUD Insertion Pain with Aspivix - Episode 230
Episode 241
Wednesday, March 13, 2024 • Duration 37:25
In this episode, we talk to Ikram Guerd, VP of Marketing at Aspivix. The Aspivix Carevix is dramatically improving the patient experience for IUD insertions and other procedures that require passage through the cervix. IUD insertions are notoriously painful but, as Ikram explains, they don’t have to be.
Join us for a conversation on medical device innovation, the history of gynecological care, and how to go viral on Tiktok. Additionally, whether you are a patient or physician, you can use the Aspivix Carevix in your procedures now. Find out how below.
For Healthcare professionals
Join our Ambassador Program to improve Women’s care. Call to all OBGYNs, midwives, nurses interested in joining the program – Contact me via my profile https://www.linkedin.com/in/ikramguerd/
For women
Looking for OBGYNs using Carevix? Check the map here as the list continues growing: https://www.aspivix.com/find-your-obgyn/ and feel free to download the brochure to engage a conversation with your OBGYN
Remember to like, rate and subscribe and enjoy the episode!
Guest bio
Passionate about young girls and women's empowerment in healthcare and in their careers, Ikram is dedicated through non-profit organizations and personally to support and advance Women’s Health practices especially in gynecology with antiquated and traumatic procedures, as well as the role of women in leadership.
Born in France, Ikram's career in marketing healthcare of 18+ years has led her to the US 7 years ago where she currently holds a position of VP of Global Marketing – Managing Director US for the innovative FemTech, ASPIVIX, whose mission is to modernize gynecology with care in mind by raising awareness around innovative solutions to reduce pain for women in gynecology.
From Lab to Market: Ovarian Cancer Diagnostic Innovation with Aspira Women’s Health - Episode 229
Episode 240
Wednesday, February 28, 2024 • Duration 50:33
In this episode, we talk to Nicole Sandford, CEO of Aspira Women’s Health, a publicly traded women’s health diagnostics company whose suite of non-invasive ovarian cancer blood tests are helping ensure women receive the best care. Nicole has an extensive background as a highly skilled operator and took the helm at Aspira in early 2022.
In their conversation, Nicole and Brittany discuss the challenges unique to ovarian cancer detection and treatment, why Aspira’s products are so revolutionary, and how the company is going after endometriosis next.
Remember to like, rate and subscribe and enjoy the episode!
Guest bio
Nicole Sandford was appointed President and Chief Executive Officer of Aspira Women's Health in February 2022 after serving as a member of the company's Board since February 2021.
Nicole brings more than three decades of executive and leadership experience to the role. Nicole has extensive experience as an innovator and business leader as well as a sought-after advisor to CEOs and Boards on strategy, operations, human capital, governance, and risk. At global consultancy Deloitte, Nicole was the executive sponsor of multiple new businesses in the life sciences/healthcare, financial services, and consumer industries where she consistently oversaw rapid, sustainable growth.
Prior to joining Aspira, Nicole was the Global Board Services Leader for boutique human capital advisory and search firm, Ellig Group, where she advised multiple Fortune 500 companies. Prior to that, she spent 27+ years with global consultancy Deloitte, launching and leading all aspects of operations for multiple businesses. She has extensive experience with complex transactions including mergers and acquisitions, financing, and both private and public securities offerings.
Organization bio
Aspira Women’s Health Inc. is transforming women’s gynecological health with the discovery, development, and commercialization of innovative testing options for women of all races and ethnicities, starting with ovarian cancer.
Their ovarian cancer risk assessment portfolio is marketed to healthcare providers as OvaSuite℠, which includes OvaWatch℠, a non-invasive, blood-based test intended for use in the initial clinical assessment of ovarian cancer risk in women with benign or indeterminate adnexal masses for which surgical intervention may be either premature or unnecessary. With a negative predictive value (NPV) of 99%, OvaWatch allows physicians to confidently rule out ovarian cancer malignancy and choose the appropriate clinical management for the right patient at the right time. Ova1Plus® combines our FDA-cleared products, Ova1® and Overa®, to detect risk of ovarian malignancy in women with adnexal masses planned for surgery.
VCs for Repro: Abortion is Your Business - Episode 228
Episode 239
Wednesday, February 14, 2024 • Duration 43:59
In this episode, we talk to Janna Meyrowitz Turner, co-founder of VCs for Repro. Dedicated to championing reproductive rights within the venture capital landscape, VCs for Repro strives to dismantle barriers and biases surrounding reproductive health, justice, and equity.
Their coalition member firms are reshaping the conversation around reproductive rights, ensuring that entrepreneurs and innovators in the space have access to the resources and support they need to thrive.
Remember to like, rate and subscribe and enjoy the episode!
Guest bio
Janna Meyrowitz Turner is a strategist focused on systems change, leadership development, and communication in all its forms.
She started her first company, Style House, at the age of 23 in 2006 which became an award-winning strategic communications and business development consultancy known for taking a holistic, progressive, and multicultural lens to brand building, strategic partnerships, platform development, marketing, and communications. With clients ranging from Estee Lauder to the WNBA, Janna became a trusted advisor to senior leadership teams on a broad range of issues - from internal and external affairs, preparation for board meetings, company retreats, and other pivotal public moments.
Today she runs Synastry Capital with three main areas of focus – investing in and building startups, conducting Personal Brand Alignment with executives and entrepreneurs, high impact leaders, and other people who do lots of things, and incubating projects designed to change the ways money and power flow in the world. Janna is the co-founder of VCs For Repro, honored as a Fast Company “World Changing Idea” for 2023, and she also sits on the board of A CALL TO MEN, a national violence prevention organization training and educating men and boys on healthy manhood.
Organization bio
VCs For Repro is a coalition of venture capital firms that frames abortion as an economic and innovation imperative.
The coalition began in early 2022 with a thesis that the venture capital community, with enormous power to shape society, and laser focused on innovation and the future, has an obligation to lead on reproductive rights.
Coroflo Measures What Matters: Quantifying Breast Milk - Episode 227
Episode 238
Wednesday, January 31, 2024 • Duration 46:30
In this episode, we talk to Rosanne Longmore, CEO of Coroflo. We discuss the latest research around breastfeeding, personal and cultural factors that may influence breastfeeding rates, and how Coroflo is giving parents data-driven confidence in their baby’s milk consumption.
Remember to like, rate and subscribe and enjoy the episode!
Guest bio
Rosanne Longmore is the CEO of Coroflo. Prior to Coroflo, Rosanne worked in financial services for 15 years, specializing in wealth management. She holds a degree from the University of Limerick, and further industry qualifications from the Institute of Project Management and the Institute of Bankers.
Organization bio
Coroflo is the company behind Coro - the world’s first accurate breastfeeding monitor, enabling parents to know exactly how much milk their baby is getting. Founded in 2017, Coroflo holds the worldwide patent for Coro, and has won numerous European and global innovation awards. To date, the company has raised $8m in funding.
FemTech Focus Podcast bio
The FemTech Focus Podcast is brought to you by FemHealth Insights, the leader in Women’s Health market research and consulting. In this show, Dr. Brittany Barreto hosts meaningfully provocative conversations that bring FemTech experts - including doctors, scientists, inventors, and founders - on air to talk about the innovative technology, services, and products (collectively known as FemTech) that are improving women's health and wellness. Though many leaders in FemTech are women, this podcast is not specifically about female founders, nor is it geared toward a specifically female audience. The podcast gives our host, Dr. Brittany Barreto, and guests an engaging, friendly environment to learn about the past, present, and future of women’s health and wellness.
FemHealth Insights bio
Led by a team of analysts and advisors who specialize in female health, FemHealth Insights is a female health-specific market research and analysis firm, offering businesses in diverse industries unparalleled access to the comprehensive data and insights needed to illuminate areas of untapped potential in the nuanced women’s health market.
Time Stamps
[2:17] Interview Start +1:12
Episode Contributors
Decoding the Vaginal Microbiome with Evvy - Episode 226
Episode 237
Wednesday, January 17, 2024 • Duration 45:13
In this episode, we talk to Priyanka Jain, Co-Founder and CEO of Evvy. We discuss what Evvy is, biomarkers in the vaginal microbiome and the future of vaginal healthcare. Don’t forget, you can get $10 off your Evvy kit using promocode FEMHEALTH10.
Remember to like, rate and subscribe and enjoy the episode!
Guest bio
Priyanka is the co-founder & CEO of Evvy, where her mission is to close the gender health data gap. Evvy is unlocking precision female healthcare through researching novel female biomarkers, starting with the vaginal microbiome. Before founding Evvy, Priyanka was Head of Product at pymetrics, a startup using behavioral science and AI to make talent matching more effective and fair. She is also a spokesperson for the United Nations Foundation's Girl Up Campaign and on the Innovation Board for the XPRIZE Foundation. She received her B.S. from Stanford University, where she was a Mayfield Fellow and President of Stanford Women in Business.
Organization bio
Evvy is closing the gender health gap by leveraging overlooked female biomarkers, starting with the vaginal microbiome. Evvy’s innovative vaginal healthcare platform, powered by their groundbreaking vaginal microbiome test, is the first to combine state-of-the-art testing, precision care, and coaching to give women and people with vaginas the care they deserve.
FemTech Focus Podcast bio
The FemTech Focus Podcast is brought to you by FemHealth Insights, the leader in Women’s Health market research and consulting. In this show, Dr. Brittany Barreto hosts meaningfully provocative conversations that bring FemTech experts - including doctors, scientists, inventors, and founders - on air to talk about the innovative technology, services, and products (collectively known as FemTech) that are improving women's health and wellness. Though many leaders in FemTech are women, this podcast is not specifically about female founders, nor is it geared toward a specifically female audience. The podcast gives our host, Dr. Brittany Barreto, and guests an engaging, friendly environment to learn about the past, present, and future of women’s health and wellness.
FemHealth Insights bio
Led by a team of analysts and advisors who specialize in female health, FemHealth Insights is a female health-specific market research and analysis firm, offering businesses in diverse industries unparalleled access to the comprehensive data and insights needed to illuminate areas of untapped potential in the nuanced women’s health market.
Time StampsEpisode Contributors
Related Shows Based on Content Similarities
Discover shows related to FemTech Focus, based on actual content similarities. Explore podcasts with similar topics, themes, and formats, backed by real data.
Led by a team of analysts and advisors who specialize in female health, FemHealth Insights is a female health-specific market research and analysis firm, offering businesses in diverse industries unparalleled access to the comprehensive data and insights needed to illuminate areas of untapped potential in the nuanced women’s health market.
[02:00] Gaia’s background
[03:42] Founding story of Hale
[05:22] What is vulvodynia? What causes it?
[08:57] How is vulvodynia treated?
[10:02] How does physiotherapy help with vulvodynia?
[13:13] The role of community in treating chronic pelvic pain
[15:18] What is Hale?
[19:20] Who can access Hale? Where is it
[22:08] FemTech in the EU
[28:10] Marketing censorship of women’s health companies in the EU
[28:36] Women’s Health trends and access to research funding in the EU vs US
[30:40] Advice for european entrepreneurs wanting to build in women’s health
In 2022, Thirty Madison merged with Nurx, the leading digital healthcare platform for women. The combined entity now covers a wide range of chronic, sexual health, and women’s health conditions through both digital and at-home care.
The FemTech Focus Podcast is brought to you by FemHealth Insights, the leader in Women’s Health market research and consulting. In this show, Dr. Brittany Barreto hosts meaningfully provocative conversations that bring FemTech experts - including doctors, scientists, inventors, and founders - on air to talk about the innovative technology, services, and products (collectively known as FemTech) that are improving women's health and wellness. Though many leaders in FemTech are women, this podcast is not specifically about female founders, nor is it geared toward a specifically female audience. The podcast gives our host, Dr. Brittany Barreto, and guests an engaging, friendly environment to learn about the past, present, and future of women’s health and wellness.
Led by a team of analysts and advisors who specialize in female health, FemHealth Insights is a female health-specific market research and analysis firm, offering businesses in diverse industries unparalleled access to the comprehensive data and insights needed to illuminate areas of untapped potential in the nuanced women’s health market.
[05:50] How Michelle got into digital health
[07:30] What is Thirty Madison?
[09:12] ⅓ of women’s health patients at Thirty Madison live in women’s health desert
[10:02] NURX is the leading digital healthcare company for women
[11:48] Who is the ideal NURX customer?
[14:40] Accessible and affordable – that’s what NURX is about
[18:52] Product offerings at Thirty Madison
[20:40] Birth control side effects + finding the right birth control for you using digital health
[23:40] What are some of the challenges faced? Capital, differentiation, scale.
[31:03] Lessons learned at a large healthcare company that Michelle has brought to her role
[35:24] Thirty Madison fundraising process
[36:54] Make sure your investors understand and believe in the mission of your business
Led by a team of analysts and advisors who specialize in female health, FemHealth Insights is a female health-specific market research and analysis firm, offering businesses in diverse industries unparalleled access to the comprehensive data and insights needed to illuminate areas of untapped potential in the nuanced women’s health market.
[04:30] Investment thesis for new fund focused on women’s health [06:15] Startup opportunities in LATAM [08:50] Where Daniela and New Ventures are seeing the most opportunity within FemTech [09:35] 25% of women in Latin America have a child before the age of 18 [11:28] Market size of FemTech in LATAM [13:10] Abortion legislation and access across LATAM [19:50] Who pays for healthcare in LATAM? [22:50] Key factors Daniela and New Ventures are looking for in deals [24:10] What are predominant business models for FemTech companies in LATAM? [25:50] What is the FemTech market size in LATAM? [32:38] Cultural considerations for expanding FemTech companies internationally [33:50] Groups, events, and organizations to connect with FemTech community in LATAM [39:05] Women’s health is about more than women [39:30] How to get in touch with Daniela and New Ventures
Daniela Pacheco LinkedIn: @Daniela Pacheco
New Ventures + Empodera Impact Capital Website: https://nvcapital.vc/ LinkedIn: @Empodera Impact Capital
Led by a team of analysts and advisors who specialize in female health, FemHealth Insights is a female health-specific market research and analysis firm, offering businesses in diverse industries unparalleled access to the comprehensive data and insights needed to illuminate areas of untapped potential in the nuanced women’s health market.
[02:45] Female investors as force multiplier in women’s health
[03:00] Alexandria’s background
[05:15] Discovering the power of nutrition in overall health
[06:35] What is Poplin? Why should individuals and couples care about preconception health?
[09:00] Preconception rituals in various cultures over time
[12:12] Fertility is an extension of your overall health. Poplin is looking at 10x the biomarkers of other fertility companies.
[13:01] Poplin testing often uncovers other underlying health conditions that are interfering with their ability to get pregnant, even if they feel well
[14:23] Why “How you feel” is not a great indicator of health
[15:37] Nutrient deficiencies that impact fertility
[19:15] What does it look like to use Poplin?
[22:01] How long does it take for interventions to be effective?
[24:13] Alexandria wrote a book!
[29:30] Who should read it?
[31:09] Fertility is a marker of future health, so whether or not you want to have kids, you should focus on your reproductive health
[32:37] Just because symptoms are common, does not mean they are normal
[33:28] Biohacking your menstrual cycle and fertility journey
[34:45] What are the biggest challenges you have faced in building Poplin?
[36:18] When we are sick, we focus inwards on ourselves and getting ourselves better. When we are well, we focus outwards on others. More and more people today are being born sick (chronic conditions, etc.).
Aspivix is a Women’s Health med device company based in Switzerland developing next-generation devices for gynecology.
Their flagship product - Carevix™ - is the world’s first suction cervical stabilizer clinically proven to reduce pain and bleeding associated with transcervical procedures commonly performed in gynecology e.g., IUD insertion, hysteroscopy, cervical biopsies, fertility treatments.
The FemTech Focus Podcast is brought to you by FemHealth Insights, the leader in Women’s Health market research and consulting. In this show, Dr. Brittany Barreto hosts meaningfully provocative conversations that bring FemTech experts - including doctors, scientists, inventors, and founders - on air to talk about the innovative technology, services, and products (collectively known as FemTech) that are improving women's health and wellness. Though many leaders in FemTech are women, this podcast is not specifically about female founders, nor is it geared toward a specifically female audience. The podcast gives our host, Dr. Brittany Barreto, and guests an engaging, friendly environment to learn about the past, present, and future of women’s health and wellness.
Led by a team of analysts and advisors who specialize in female health, FemHealth Insights is a female health-specific market research and analysis firm, offering businesses in diverse industries unparalleled access to the comprehensive data and insights needed to illuminate areas of untapped potential in the nuanced women’s health market.
[2:50] The time Ikram and Brittany went viral on TikTok! [6:55] What is Aspivix? [8:50] What is an IUD? [10:50] Being a woman has inherent pain, how can we combat this pain? [11:14] How IUDs are inserted [12:44] What is a tenaculum and what role has it played in the history of the gynecology [15:20] Use of pain medication in IUD insertions [22:30] Healthcare shouldn’t be torture, it should be healthcare [22:45] How can women get access to Aspivix products? [27:20] Fundraising when investors don’t have experience with the product [29:05] Other areas of gynecological care that need innovating [31:40] Future vision for Aspivix [33:36] The TSA vs the tenaculum [34:40] What does femtech most need right now to be successful
EndoCheck℠, Aspira’s first-of-its-kind non-invasive diagnostic test for endometriosis, is currently in development.
The FemTech Focus Podcast is brought to you by FemHealth Insights, the leader in Women’s Health market research and consulting. In this show, Dr. Brittany Barreto hosts meaningfully provocative conversations that bring FemTech experts - including doctors, scientists, inventors, and founders - on air to talk about the innovative technology, services, and products (collectively known as FemTech) that are improving women's health and wellness. Though many leaders in FemTech are women, this podcast is not specifically about female founders, nor is it geared toward a specifically female audience. The podcast gives our host, Dr. Brittany Barreto, and guests an engaging, friendly environment to learn about the past, present, and future of women’s health and wellness.
FemHealth Insights bio
Led by a team of analysts and advisors who specialize in female health, FemHealth Insights is a female health-specific market research and analysis firm, offering businesses in diverse industries unparalleled access to the comprehensive data and insights needed to illuminate areas of untapped potential in the nuanced women’s health market.
[3:25] Nicole’s background
[10:13] Being a publicly traded women’s health company
[13:08] Educating the public (and public markets!) about the importance of ovaries for health
[14:48] Aspira has the only complete suite of ovarian cancer blood tests on the market
[15:13] Why Ovarian cancer diagnostics and treatment are differently challenging than other cancers
[18:11] Why doesn’t everyone just have their ovaries removed when they discover a mass?
[19:37] Ovarian cysts vs masses
[27:23] Risk factors for and symptoms of ovarian cancer
[28:25] FDA clearance journey for novel diagnostic like Aspira’s
[32:43] Other tests in development at Aspira
[36:22] Pain is not required for endometriosis
[39:02] State of women’s health care today
[42:40] Economic burden of lack of access to diagnostics and treatments for these women’s health conditions
[43:43] Why Aspira is poised for success. What early-stage women’s health startups can learn from public companies like Aspira
The FemTech Focus Podcast is brought to you by FemHealth Insights, the leader in Women’s Health market research and consulting. In this show, Dr. Brittany Barreto hosts meaningfully provocative conversations that bring FemTech experts - including doctors, scientists, inventors, and founders - on air to talk about the innovative technology, services, and products (collectively known as FemTech) that are improving women's health and wellness. Though many leaders in FemTech are women, this podcast is not specifically about female founders, nor is it geared toward a specifically female audience. The podcast gives our host, Dr. Brittany Barreto, and guests an engaging, friendly environment to learn about the past, present, and future of women’s health and wellness.
FemHealth Insights bio
Led by a team of analysts and advisors who specialize in female health, FemHealth Insights is a female health-specific market research and analysis firm, offering businesses in diverse industries unparalleled access to the comprehensive data and insights needed to illuminate areas of untapped potential in the nuanced women’s health market.
[5:02] Janna intro
[7:38] Defining personal brand alignment
[15:25] Origin of VCs for Repro
[16:10] Personhood laws and their impact to women and women’s health companies
[19:25] Role of risk in women’s health investment
[24:15] Who is part of VCs for Repro? Why do they join?
[27:00] People underestimate their power and influence
[29:18] Abortion as a tool of economic suppression
[33:00] How to get involved in VCs for Repro
[36:00] Financial impact of reproductive rights and misogyny
[38:30] Call to action – fund abortion access, talk about abortion with others
